At the 2025 Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), His Highness Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of the Interior, left a lasting impression with his visit, marking a pivotal moment in the global healthcare landscape. With more than 1,400 companies participating and 155 distinguished speakers gracing the event, DUPHAT 2025 served as a melting pot for groundbreaking ideas in pharmaceuticals, technology, and education. Sheikh Saif’s tour of the exhibition halls was a significant highlight, where he witnessed firsthand the future of healthcare innovation.
One of the standout moments of the event was the announcement of the DUPHAT Pharmaceutical College, a revolutionary new institution aimed at advancing pharmaceutical science and research. Established in collaboration with the Abdulsalam AlMadani Global Education Centre and UCAM University in Spain, the college will offer a range of academic programs including doctorate degrees, master’s degrees, diplomas, and specialized courses in pharmaceutical sciences. This initiative is a significant leap forward in nurturing the next generation of healthcare leaders, ensuring that the UAE continues to lead in global health innovations.
Sheikh Saif’s visit not only highlighted the UAE’s commitment to being at the forefront of technological advancements in the medical sector but also underscored the country’s dedication to promoting sustainable healthcare solutions. The event also introduced “VitaShow Dubai,” a new platform for showcasing dietary supplements, functional foods, and innovative health products. The UAE’s role in advancing global health was further emphasized as the conference attracted leaders from around the world, ensuring that discussions surrounding the future of healthcare are global, collaborative, and inclusive.
DUPHAT 2025, with its emphasis on education, innovation, and international collaboration, epitomizes the UAE’s ongoing commitment to shaping the future of global healthcare and maintaining its position as a global hub for cutting-edge medical research.
